Literature DB >> 17170416

Osteoporosis and its management.

Kenneth E S Poole1, Juliet E Compston.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17170416      PMCID： PMC1702459          DOI： 10.1136/bmj.39050.597350.47

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  29 in total

1.  Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989.

Authors:  C Cooper; E J Atkinson; W M O'Fallon; L J Melton
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

2.  Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Authors:  J Y Reginster; E Seeman; M C De Vernejoul; S Adami; J Compston; C Phenekos; J P Devogelaer; M Diaz Curiel; A Sawicki; S Goemaere; O H Sorensen; D Felsenberg; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

Review 3.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

4.  Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

Authors:  J Reginster; H W Minne; O H Sorensen; M Hooper; C Roux; M L Brandi; B Lund; D Ethgen; S Pack; I Roumagnac; R Eastell
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

5.  Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis.

Authors:  C M Klotzbuecher; P D Ross; P B Landsman; T A Abbott; M Berger
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

6.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

7.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Authors:  S R Cummings; S Eckert; K A Krueger; D Grady; T J Powles; J A Cauley; L Norton; T Nickelsen; N H Bjarnason; M Morrow; M E Lippman; D Black; J E Glusman; A Costa; V C Jordan
Journal:  JAMA       Date:  1999-06-16       Impact factor: 56.272

8.  Prevention of falls in the elderly trial (PROFET): a randomised controlled trial.

Authors:  J Close; M Ellis; R Hooper; E Glucksman; S Jackson; C Swift
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

9.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

10.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321
View more
  48 in total

1.  Costo-iliac distance: a physical sign of understated importance.

Authors:  P J Barry; D O'Mahony
Journal:  Ir J Med Sci       Date:  2011-10-09       Impact factor: 1.568

2.  What of Asian, African, and South American patients?

Authors:  Suranjith L Seneviratne; Padmalal Gurugama; Devaka J Fernando
Journal:  BMJ       Date:  2007-01-06

Review 3.  Shifting the focus in fracture prevention from osteoporosis to falls.

Authors:  Teppo L N Järvinen; Harri Sievänen; Karim M Khan; Ari Heinonen; Pekka Kannus
Journal:  BMJ       Date:  2008-01-19

4.  NOX4 Deletion in Male Mice Exacerbates the Effect of Ethanol on Trabecular Bone and Osteoblastogenesis.

Authors:  James Watt; Alexander W Alund; Casey F Pulliam; Kelly E Mercer; Larry J Suva; Jin-Ran Chen; Martin J J Ronis
Journal:  J Pharmacol Exp Ther       Date:  2018-04-13       Impact factor: 4.030

Review 5.  Conservative management of osteoporotic vertebral fractures: an update.

Authors:  A Slavici; M Rauschmann; C Fleege
Journal:  Eur J Trauma Emerg Surg       Date:  2016-12-26       Impact factor: 3.693

6.  NICE: Its Influence in Treating Osteoporosis in the UK and beyond.

Authors:  Juliet Compston
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

7.  Risk factors for nonvertebral fracture in obese older women.

Authors:  M O Premaor; K Ensrud; L Lui; R A Parker; J Cauley; T A Hillier; S Cummings; J E Compston
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

8.  Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.

Authors:  Karine Castro-Lionard; Patricia Dargent-Molina; Christophe Fermanian; Régis Gonthier; Bernard Cassou
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

9.  Association between delivery at an advanced maternal age and osteoporosis in elderly Korean women.

Authors:  Eunju Ahn; Jungkwon Lee; Yong Soon Park; Hye-Mi Noh; Bo Ha Kim
Journal:  J Bone Miner Metab       Date:  2014-10-11       Impact factor: 2.626

10.  Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies.

Authors:  P M Ciaschini; S E Straus; L R Dolovich; R A Goeree; K M Leung; C R Woods; G M Zimmerman; S R Majumdar; S Spadafora; L A Fera; H N Lee
Journal:  Trials       Date:  2008-11-04       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.